pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    ACE-1702
    Solid Tumor Acepodia Inc
  • Phase 2
    ACE-1831
    Immunoglobulin G4-Related Disease (IgG4-RD) Acepodia Inc
  • Phase 1
    ACE-2016
    Solid Tumor Acepodia Inc
  • Phase 1
← prev
page 50 of 271
next →
Pain89
Neurology1
ACE-232
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Acerand Therapeutics
  • ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG
    ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG (ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG TABLETS)
    no indication TARO
  • ACETAMINOPHEN AND CODEINE
    ACETAMINOPHEN AND CODEINE
    no indication AMNEAL PHARMS NY
  • ACETAMINOPHEN AND CODEINE PHOSPHATE
    ACETAMINOPHEN AND CODEINE PHOSPHATE (ACETAMINOPHEN)
    no indication Eon Labs Inc
  • ACETAMINOPHEN AND IBUPROFEN
    ACETAMINOPHEN AND IBUPROFEN (ACETAMINOPHEN)
    Uses temporarily relieves minor aches and pains due to: h…$PRGO PERRIGO Co plc
  • Phase 2
    ACI-24060
    Alzheimer's Disease$ACIU AC Immune SA
  • Phase 1
    ACLX-001
    Refractory Multiple Myeloma$ACLX Arcellx, Inc.
  • Preclinical
    ACM-002
    Amyotrophic Lateral Sclerosis Actimed Therapeutics Ltd
  • Phase 2
    ACP-01
    Vescell
    Chronic Stable Angina Hemostemix Inc
  • Phase 2
    ACP-017
    Cutaneous Squamous Cell Carcinoma (cSCC) Ascendis Pharma AS
  • Phase 1
    ACR-2316
    Endometrial Cancer$ACRV Acrivon Therapeutics, Inc.
  • Phase 2
    ACT-001
    Pediatric Diffuse Intrinsic Pontine Glioma Accendatech Co Ltd
  • Phase 1
    ACT-101
    Myasthenia Gravis Alpha Cancer Technologies Inc
  • Preclinical
    ACT-111
    Spinal Cord Injury Asia Cell & Gene Therapeutics (Zhejiang) Co Ltd
  • Preclinical
    ACT-903
    Hematological Tumor Alpha Cancer Technologies Inc
  • ACTEMRA
    ACTEMRA (TOCILIZUMAB)
    no indication Genentech Inc
  • Phase 2
    ACTX-401
    Spinal Muscular Atrophy (SMA) Alcyone Therapeutics Inc
  • Preclinical
    ACXT-3102
    Pancreatic Ductal Adenocarcinoma Accuronix Therapeutics Inc
  • Preclinical
    AChE Inhibitors
    Acne Vulgaris Attillaps Holdings Inc
  • Phase 3
    AD-109
    (atomoxetine [INN] + oxybutynin)
    Obstructive Sleep Apnea Apnimed Inc
  • ADAPALENE AND BENZOYL PEROXIDE
    ADAPALENE AND BENZOYL PEROXIDE (ADAPALENE AND BENZOYL PEROXIDE TOPICAL)
    no indication ALEMBIC
  • ADAPALENE AND BENZOYL PEROXIDE GEL, 0.1%/2.5%
    ADAPALENE AND BENZOYL PEROXIDE GEL, 0.1%/2.5%
    no indication ENCUBE
  • ADAPALENE GEL USP, 0.3%
    ADAPALENE GEL USP, 0.3%
    no indication ENCUBE ETHICALS
  • Preclinical
    ADB-101
    Erythromelalgia Adolore Biotherapeutics Inc
  • Preclinical
    ADB-115
    ulinastatin [INN]
    Pancreatitis Jiangsu Aidea Pharmaceutical Group Co Ltd
  • ADBRY
    ADBRY (TRALOKINUMAB)
    no indication Leo Pharma AS
  • Preclinical
    ADC
    Unspecified Cancer Kind Pharmaceuticals